As income and wealth inequality continue to divide Americans into two distinct classes and levels of wealth, those who are ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023 ...

A report suggests that a proposed tariff could significantly increase medicine costs in America. The analysis estimates a ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.